| ||||||||||||||
|
|
|||||||||||||

Departments of
*Pharmacology and
Anesthesiology and Research Laboratory of Anesthesia, State University of Campinas, São Paulo, Brazil
Address correspondence and reprint requests to Jose Eduardo Tanus-Santos, MD, PhD, Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas, PO Box 6111, 13083-970 Campinas, São Paulo, Brazil. Address e-mail to tanus@ unicamp.br.
Endothelin (ET) is involved in the humoral component of the vasoconstriction during pulmonary embolism. We examined the effects of selective ET receptor antagonists on the hemodynamic and respiratory changes and on serum thromboxane B2 (TXB2) levels, during a continuous venous air infusion (VAI) in anesthetized mongrel dogs. The VAI (0.2 mL · kg-1 · min-1) was initiated 5 min after an injection of saline (controls, n = 7), 1 µmol of the selective ETA receptor antagonist JKC-301 (group A, n = 6), or 1 µmol of the selective ETB receptor antagonist BQ-788 (group B, n = 6). Hemodynamic evaluation was performed every 15 min of VAI, and blood samples were drawn for blood gas analysis and TXB2 determinations. The increase in pulmonary perfusion pressure after 30 min of VAI was attenuated in Group A compared with the controls and Group B (Group A = 7 ± 1 mm Hg; Group B = 16 ± 1 mm Hg; controls = 14 ± 1 mm Hg; P < 0.05). Pulmonary vascular resistance showed a similar behavior. TXB2 concentrations increased after 60 min of VAI in the controls and in Group B, but not in Group A (controls = 48%; Group B = 104%; Group A = 18%; P < 0.05 for controls and Group B). Similar decreases in PaO2 and SaO2 were observed in the three groups. We conclude that antagonism of ETA receptors attenuates the hemodynamic changes and blunts the increase in thromboxane A2 production during a VAI in dogs.
Implications: We evaluated the effects of endothelin receptor antagonists during a venous air infusion in dogs. EndothelinA receptor antagonism attenuated the hemodynamic changes and blunted the increase in thromboxane A2 production in this setting.
This article has been cited by other articles:
![]() |
D. C. Souza-Costa, T. Zerbini, A. C. Palei, R. F. Gerlach, and J. E. Tanus-Santos L-arginine Attenuates Acute Pulmonary Embolism-Induced Increases in Lung Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Chest, November 1, 2005; 128(5): 3705 - 3710. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C.T. Palei, R. A.G. Zaneti, G. M. Fortuna, R. F. Gerlach, and J. E. Tanus-Santos Hemodynamic Benefits of Matrix Metalloproteinase-9 Inhibition by Doxycycline During Experimental Acute Pulmonary Embolism Angiology, September 1, 2005; 56(5): 611 - 617. [Abstract] [PDF] |
||||
![]() |
C. A. Dias-Junior, D. C. Souza-Costa, T. Zerbini, J. B. T. da Rocha, R. F. Gerlach, and J. E. Tanus-Santos The Effect of Sildenafil on Pulmonary Embolism-Induced Oxidative Stress and Pulmonary Hypertension Anesth. Analg., July 1, 2005; 101(1): 115 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Tanus-Santos Pharmacologic Therapy of Pulmonary Vasoconstriction in Acute Pulmonary Embolism Anesth. Analg., January 1, 2004; 98(1): 273 - 273. [Full Text] [PDF] |
||||
![]() |
D. Merkus, D. J. Duncker, and W. M. Chilian Metabolic regulation of coronary vascular tone: role of endothelin-1 Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1915 - H1921. [Abstract] [Full Text] [PDF] |
||||
|